2012 NIFMSE Schedule
Conferences and an opening reception are on Wednesday; the trade show from 9 a.m. to 4 p.m. Thursday and 9 a.m. to 1 p.m. Friday.
It will be the 16th annual show in Las Vegas.
The conference schedule includes:
• Fastener Technology Workshop by the Fastener Training Institute from 8:30 a.m. to 4:30 p.m. Bengt Blendulf of EduPro US Inc. is the instructor.
• Protect Your Company / Technical Knowledge Policies as a Risk Management Tool at 2 pm. Carmen Vertullo is the instructor. Presented by the Pacific-West Fastener Association.
• Women in Leadership: An Evolving Perspective, 2 pm to 4 pm. Sandra Cardillo, president of Conrad Associates speaking. Presented by the Women in the Fastener Industry.
• Fastener & Mill Supply Industry Finance, Controllers, Credit & Accounting Managers Meeting, 9 am-3 pm. Presented by the National Fastener Industry Finance Manager Network and the Business Credit Management Association.
There will be an opening reception from 6 pm to 7 pm Wednesday at Harrah’s Hotel.
As of the end of July the pace of booth sales for the 2012 National Industrial Fastener & Mill Supply Expo are up more than 5%.
Show manager Susan Hurley reported 566 companies have booked 730 booths. A year ago there were 522 companies totaling 690 booths, Hurley told GlobalFastenerNews.com.
The trade show will be October 10-12, 2012 at the Sands Expo & Convention Center in Las Vegas.
The NIFMSE record is 829 booths in 2007 at Mandalay Bay in Las Vegas.
The show was first held in 1981 in Columbus, OH. The largest Ohio show was 653 booths in 1998.
Exhibitors booked thus far come from 18 countries, Hurley said.
The trade show industry is reporting higher numbers thus far this year. Hurley cited a Center for Exhibition Industry Research report showing the first quarter CEIR Index was up 2.7% over 2011.
CEIR noted that all four key trade show measures improved, led by professional attendance. The CEIR Index pegged attendance up 4.6% in the first quarter; net sq ft of exhibit space rose 3.4% and the number of exhibitors and real revenue each were up 1.5%.
There are no comments at the moment, do you want to add one?
Write a comment